Insider Transactions Reported by 30 Insiders of Celularity Inc

Symbol: CELU, CELUW on Nasdaq
Location: Florham Park, NJ

Quick Takeaways

CELU - Celularity Inc has 30 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are available for direct filing-level review.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 15 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Celularity Inc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Lim Kok Thay	10%+ Owner	$13,119,993	Mixed	24 Jul 2025
Dragasac Ltd	10%+ Owner	$7,485,632	Mixed	16 Jul 2021
Robert J. Hariri	Chief Executive Officer, Director	$4,681,765	Mixed	13 Apr 2025
STARR INTERNATIONAL CO INC	10%+ Owner	$3,805,066	Mixed	01 Mar 2022
Sorrento Therapeutics, Inc.	10%+ Owner	$1,257,556	Mixed	29 Sep 2023
Dean C. Kehler	Director	$1,247,311	Mixed	19 Dec 2024
Diane L. Parks	Director	$577,223	Mixed	12 Jan 2026
Adrian Kilcoyne	Chief Medical Officer	$487,051	Mixed	16 Feb 2024
Peter Diamandis	Director	$437,506	Mixed	12 Jan 2026
Berhad Genting	10%+ Owner	$375,000	Mixed	20 Jun 2023
Geoffrey Ling MD	Director	$284,188	Mixed	12 Jan 2026
Richard J. Berman	Director	$277,080	Mixed	19 Dec 2024
John Sculley	Director	$250,160	Mixed	14 Jun 2023
Vincent LeVien	Director	$170,770	Mixed	12 Jan 2026
Bradley Glover	Executive Vice President, Chief Operating Officer	$87,447	Mixed	13 Apr 2023
Kyle Fletcher	Executive Vice President, General Counsel	$86,659	Mixed	13 Apr 2024
Andrew C. von Eschenbach	Director	$83,680	Mixed	14 Jun 2023
Marc Mazur	Director	$58,780	Mixed	14 Jun 2023
Robin L. Smith	Director	$58,780	Mixed	14 Jun 2023
John R. Haines	Senior Exec Vice President	$50,449	Mixed	13 Apr 2025
David C. Beers	Chief Financial Officer	$32,044	Mixed	13 Apr 2025
GX Sponsor LLC	10%+ Owner	$24,900	Mixed	16 Jul 2021
Stephen Brigido	Pres., Functional Regeneration	$15,975	Mixed	13 Apr 2025
Anne Jones	Chief Business Officer	$12,239	Mixed	13 Jul 2022
Keary Dunn	General Counsel & Executive Vice President	$4,085	Mixed	13 Apr 2022
Joseph DosSantos	Interim CFO		Mixed	10 Jun 2025
Jay R. Bloom	Director		Mixed	09 Sep 2021
Resorts World Inc Pte. Ltd.	10%+ Owner		Mixed	15 Jul 2024
Beloo Mirakhur	EVP, Clinical Development		Mixed	13 Sep 2021
Andrew L. Pecora	President		Mixed	15 Sep 2021

Top shareholders of Celularity Inc (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Dragasac Ltd	13D/G 3/4/5	Lim Kok Thay · 10%+ Owner	41%	14,138,161	$27,710,796	+$8,232,000	24 Jul 2025	13D/G 3/4/5
Lim Kok Thay	3/4/5	10%+ Owner	— mixed-class rows	10,538,161 mixed-class rows	$13,119,993	—	24 Jul 2025	3/4/5
Robert J. Hariri	3/4/5	Chief Executive Officer, Director	— mixed-class rows	2,854,735 mixed-class rows	$4,681,765	—	13 Apr 2025	3/4/5
STARR INTERNATIONAL CO INC	3/4/5	10%+ Owner	— class O/S missing	15,281,389	$3,805,066	—	01 Mar 2022	3/4/5
C V STARR & CO INC	13F	Company	3.2%	764,069	$1,581,623	—	31 Dec 2025	13F
Sorrento Therapeutics, Inc.	3/4/5	10%+ Owner	— class O/S missing	5,050,427	$1,257,556	—	29 Sep 2023	3/4/5
Dean C. Kehler	3/4/5	Director	— mixed-class rows	666,006 mixed-class rows	$1,247,311	—	19 Dec 2024	3/4/5
VANGUARD GROUP INC	13F	Company	2.8%	676,650	$751,082	—	31 Dec 2025	13F
Diane L. Parks	3/4/5	Director	— mixed-class rows	1,038,795 mixed-class rows	$577,223	—	12 Jan 2026	3/4/5
Adrian Kilcoyne	3/4/5	Chief Medical Officer	— mixed-class rows	1,327,451 mixed-class rows	$487,051	—	16 Feb 2024	3/4/5
Peter Diamandis	3/4/5	Director	— mixed-class rows	1,329,383 mixed-class rows	$437,506	—	12 Jan 2026	3/4/5
Berhad Genting	3/4/5	10%+ Owner	— class O/S missing	3,000,000	$375,000	—	20 Jun 2023	3/4/5
Geoffrey Ling MD	3/4/5	Director	— mixed-class rows	1,747,022 mixed-class rows	$284,188	—	12 Jan 2026	3/4/5
Richard J. Berman	3/4/5	Director	— mixed-class rows	388,384 mixed-class rows	$277,080	—	19 Dec 2024	3/4/5
John Sculley	3/4/5	Director	— mixed-class rows	1,282,438 mixed-class rows	$250,160	—	14 Jun 2023	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.67%	160,190	$177,843	—	31 Dec 2025	13F
BRISTOL MYERS SQUIBB CO	13D/G	—	1.9%	426,372	$174,813	$0	31 Dec 2024	13D/G
Vincent LeVien	3/4/5	Director	— mixed-class rows	310,097 mixed-class rows	$170,770	—	12 Jan 2026	3/4/5
BlackRock, Inc.	13F	Company	0.48%	114,855	$127,488	—	31 Dec 2025	13F
Bradley Glover	3/4/5	Executive Vice President, Chief Operating Officer	— class O/S missing	351,192	$87,447	—	13 Apr 2023	3/4/5
Kyle Fletcher	3/4/5	Executive Vice President, General Counsel	— mixed-class rows	185,256 mixed-class rows	$86,659	—	13 Apr 2024	3/4/5
CITADEL ADVISORS LLC	13F	Company	0.32%	77,657	$86,199	—	31 Dec 2025	13F
Andrew C. von Eschenbach	3/4/5	Director	— mixed-class rows	613,844 mixed-class rows	$83,680	—	14 Jun 2023	3/4/5
STATE STREET CORP	13F	Company	0.24%	57,830	$64,191	—	31 Dec 2025	13F
Marc Mazur	3/4/5	Director	— mixed-class rows	513,844 mixed-class rows	$58,780	—	14 Jun 2023	3/4/5
Robin L. Smith	3/4/5	Director	— mixed-class rows	513,844 mixed-class rows	$58,780	—	14 Jun 2023	3/4/5
Valmark Advisers, Inc.	13F	Company	0.21%	49,983	$55,481	—	31 Dec 2025	13F
John R. Haines	3/4/5	Senior Exec Vice President	— mixed-class rows	30,762 mixed-class rows	$50,449	—	13 Apr 2025	3/4/5
NORTHERN TRUST CORP	13F	Company	0.18%	44,163	$49,021	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.17%	41,312	$45,856	—	31 Dec 2025	13F
HB Wealth Management, LLC	13F	Company	0.17%	40,415	$44,861	—	31 Dec 2025	13F
Biltmore Family Office, LLC	13F	Company	0.15%	35,000	$38,850	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.12%	29,315	$32,540	—	31 Dec 2025	13F
David C. Beers	3/4/5	Chief Financial Officer	— mixed-class rows	19,226 mixed-class rows	$32,044	—	13 Apr 2025	3/4/5
KEYNOTE FINANCIAL SERVICES LLC	13F	Company	0.11%	25,320	$28,105	—	31 Dec 2025	13F
GX Sponsor LLC	3/4/5	10%+ Owner	— class O/S missing	100,000	$24,900	—	16 Jul 2021	3/4/5
ROYAL BANK OF CANADA	13F	Company	0.08%	18,000	$20,000	—	31 Dec 2025	13F
IPG Investment Advisors LLC	13F	Company	0.07%	17,169	$19,058	—	31 Dec 2025	13F
Stephen Brigido	3/4/5	Pres., Functional Regeneration	— mixed-class rows	9,741 mixed-class rows	$15,975	—	13 Apr 2025	3/4/5
Perennial Investment Advisors, LLC	13F	Company	0.06%	13,629	$15,128	—	31 Dec 2025	13F
Walleye Capital LLC	13F	Company	— class O/S missing	835,194	$13,614	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	11,727	$13,017	—	31 Dec 2025	13F
Anne Jones	3/4/5	Chief Business Officer	— class O/S missing	49,154	$12,239	—	13 Jul 2022	3/4/5
IFP Advisors, Inc	13F	Company	0.05%	11,000	$12,210	—	31 Dec 2025	13F
LINDEN ADVISORS LP	13F	Company	— class O/S missing	550,119	$8,967	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	4,998	$5,548	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	0.02%	4,951	$5,496	—	31 Dec 2025	13F
SIMPLEX TRADING, LLC	13F	Company	0.02%	4,603	$5,109	—	31 Dec 2025	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	— class O/S missing	350,000	$4,585	—	31 Dec 2025	13F
Keary Dunn	3/4/5	General Counsel & Executive Vice President	— mixed-class rows	64,505 mixed-class rows	$4,085	—	13 Apr 2022	3/4/5

Recent Insider Transactions by Companies or Individuals for Celularity Inc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Shares	Shares Owned	Date	Ownership
Diane L. Parks	CELU	Class A Common Stock	Award	6.12%	30,000	520,021	12 Jan 2026	Direct
Peter Diamandis	CELU	Class A Common Stock	Award	5.45%	20,385	394,150	12 Jan 2026	Direct
Geoffrey Ling MD	CELU	Class A Common Stock	Award	8.12%	19,231	256,026	12 Jan 2026	Direct
Vincent LeVien	CELU	Class A Common Stock	Award	23.1%	28,847	153,847	12 Jan 2026	Direct
Geoffrey Ling MD	CELU	Class A Common Stock	Award	111.8%	125,000	236,795	29 Dec 2025	Direct
Geoffrey Ling MD	CELU	Stock Options	Award	11.7%	156,250	1,490,996	29 Dec 2025	Direct
Vincent LeVien	CELU	Class A Common Stock	Award		125,000	125,000	29 Dec 2025	Direct
Vincent LeVien	CELU	Stock Options	Award		156,250	156,250	29 Dec 2025	Direct
Diane L. Parks	CELU	Class A Common Stock	Award	34.2%	125,000	490,021	29 Dec 2025	Direct
Diane L. Parks	CELU	Stock Options	Award	43.1%	156,250	518,774	29 Dec 2025	Direct
Peter Diamandis	CELU	Class A Common Stock	Award	50.2%	125,000	373,765	29 Dec 2025	Direct
Peter Diamandis	CELU	Stock Options	Award	43.1%	156,250	518,774	29 Dec 2025	Direct
Diane L. Parks	CELU	Class A Common Stock	Award	22.6%	67,416	365,021	19 Dec 2025	Direct
Geoffrey Ling MD	CELU	Class A Common Stock	Award	151.9%	67,416	111,795	19 Dec 2025	Direct
Peter Diamandis	CELU	Class A Common Stock	Award	37.2%	67,416	248,765	19 Dec 2025	Direct
Diane L. Parks	CELU	Class A Common Stock	Award	20.3%	61,539	365,021	19 Nov 2025	Direct
Vincent LeVien	CELU	Class A Common Stock	Award		3,699	3,699	19 Nov 2025	Direct
Geoffrey Ling MD	CELU	Class A Common Stock	Award	65.8%	44,379	111,795	19 Nov 2025	Direct
Peter Diamandis	CELU	Class A Common Stock	Award	23.3%	47,042	248,765	19 Nov 2025	Direct
Lim Kok Thay	CELU	Warrants (Right to Buy)	Other		3,700,000	3,700,000	24 Jul 2025	Direct
Lim Kok Thay	CELU	Warrants (Right to Buy)	Other		2,450,000	1,350,000	24 Jul 2025	By Resorts World Inc Pte. Ltd.
Lim Kok Thay	CELU	Warrants (Right to Buy)	Other	-100%	-1,950,000	0	24 Jul 2025	By Resorts World Inc Pte. Ltd.
Vincent LeVien	CELU	Stock Options	Award		186,336	186,336	05 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.